Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer (Q46587289)
Jump to navigation
Jump to search
scientific article published on 19 May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer |
scientific article published on 19 May 2008 |
Statements
1 reference
Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer (English)
1 reference
Anna Maria Storniolo
1 reference
Mark D Pegram
1 reference
Beth Overmoyer
1 reference
Paula Silverman
1 reference
Nancy W Peacock
1 reference
Suzanne F Jones
1 reference
Jill Loftiss
1 reference
Nikita Arya
1 reference
Kevin M Koch
1 reference
Elaine Paul
1 reference
Lini Pandite
1 reference
Ronald A Fleming
1 reference
Peter F Lebowitz
1 reference
Peter T C Ho
1 reference
Howard A Burris
1 reference
19 May 2008
1 reference
1 reference
26
1 reference
20
1 reference
3317-3323
1 reference
Identifiers
1 reference
1 reference